Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for lenvatinib combined with pembrolizumab in metastatic gastroesophageal cancer is displayed, with study details, participant criteria, treatment plan, outcomes, and a study protocol document. The study is marked completed and no longer recruiting.
    Difference
    47%
    Check dated 2026-11-11T02:11:17.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:44:53.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision advances from v3.7.1 to v3.7.2. The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:47:40.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site's displayed revision number changed from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-07T01:00:37.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the study details with an access-restriction message. The page still shows navigation elements such as a Home button and the site footer, indicating a restricted view rather than the study information.
    Difference
    0.5%
    Check dated 2026-09-30T01:03:35.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study details. This suggests restricted access or a server/configuration issue rather than a content update.
    Difference
    18%
    Check dated 2026-09-23T00:57:20.000Z thumbnail image

Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.